Your browser doesn't support javascript.
loading
Concentrations of Ustekinumab During Induction Therapy Associate With Remission in Patients With Crohn's Disease.
Soufflet, Ninon; Boschetti, Gilles; Roblin, Xavier; Cuercq, Charlotte; Williet, Nicolas; Charlois, Anne-Laure; Duclaux-Loras, Remi; Danion, Pauline; Mialon, Anne; Faure, Mathias; Paul, Stéphane; Flourie, Bernard; Nancey, Stéphane.
Afiliação
  • Soufflet N; Department of Gastroenterology, Lyon-Sud University Hospital, Hospices Civils de Lyon, Pierre Bénite, and University Claude Bernard Lyon 1, Lyon, France.
  • Boschetti G; Department of Gastroenterology, Lyon-Sud University Hospital, Hospices Civils de Lyon, Pierre Bénite, and University Claude Bernard Lyon 1, Lyon, France; INSERM U1111, International Center for Research in Infectiology, Lyon, France.
  • Roblin X; Department of Gastroenterology, University Hospital of Saint-Etienne, EA-30 64, Groupe Immunité des Muqueuses et Agents Pathogènes, and Faculty of Medicine of Saint-Etienne, Saint-Etienne, France.
  • Cuercq C; Laboratory of Biochemistry, Lyon-Sud University Hospital, Hospices Civils de Lyon, Pierre Bénite, and University Claude Bernard Lyon 1, Lyon, France.
  • Williet N; Department of Gastroenterology, University Hospital of Saint-Etienne, EA-30 64, Groupe Immunité des Muqueuses et Agents Pathogènes, and Faculty of Medicine of Saint-Etienne, Saint-Etienne, France.
  • Charlois AL; Department of Gastroenterology, Lyon-Sud University Hospital, Hospices Civils de Lyon, Pierre Bénite, and University Claude Bernard Lyon 1, Lyon, France.
  • Duclaux-Loras R; Department of Gastroenterology, Lyon-Sud University Hospital, Hospices Civils de Lyon, Pierre Bénite, and University Claude Bernard Lyon 1, Lyon, France.
  • Danion P; Department of Gastroenterology, Lyon-Sud University Hospital, Hospices Civils de Lyon, Pierre Bénite, and University Claude Bernard Lyon 1, Lyon, France.
  • Mialon A; Laboratory of Biochemistry, Lyon-Sud University Hospital, Hospices Civils de Lyon, Pierre Bénite, and University Claude Bernard Lyon 1, Lyon, France.
  • Faure M; INSERM U1111, International Center for Research in Infectiology, Lyon, France.
  • Paul S; Department of Gastroenterology, University Hospital of Saint-Etienne, EA-30 64, Groupe Immunité des Muqueuses et Agents Pathogènes, and Faculty of Medicine of Saint-Etienne, Saint-Etienne, France.
  • Flourie B; Department of Gastroenterology, Lyon-Sud University Hospital, Hospices Civils de Lyon, Pierre Bénite, and University Claude Bernard Lyon 1, Lyon, France; INSERM U1111, International Center for Research in Infectiology, Lyon, France.
  • Nancey S; Department of Gastroenterology, Lyon-Sud University Hospital, Hospices Civils de Lyon, Pierre Bénite, and University Claude Bernard Lyon 1, Lyon, France; INSERM U1111, International Center for Research in Infectiology, Lyon, France. Electronic address: stephane.nancey@chu-lyon.fr.
Clin Gastroenterol Hepatol ; 17(12): 2610-2612, 2019 11.
Article em En | MEDLINE | ID: mdl-30851477

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Indução de Remissão / Doença de Crohn / Ustekinumab Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Clin Gastroenterol Hepatol Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Indução de Remissão / Doença de Crohn / Ustekinumab Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Clin Gastroenterol Hepatol Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: França